Sophia Genetics (Sophia Genetics) Total Stockholders Equity : $132.23 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Total Stockholders Equity?

Sophia Genetics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $132.23 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sophia Genetics's Book Value per Share for the quarter that ended in Mar. 2024 was $2.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sophia Genetics's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.13.

Sophia Genetics Total Stockholders Equity Historical Data

The historical data trend for Sophia Genetics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Total Stockholders Equity Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

22.25

100.51

275.40

200.13

151.44

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial													184.91	171.70	158.44	151.44	132.23

Sophia Genetics (NAS:SOPH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sophia Genetics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(132.232	-	0)	/	65.3751
	=	2.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sophia Genetics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.704	+	14.738)	/	132.232
	=	0.13

Sophia Genetics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics (Sophia Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

Rue du Centre 172, Saint-Sulpice, CHE, CH-1025

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.